Bogusch Leah M, O'Brien William H
a Psychology Department , Bowling Green State University.
Behav Med. 2019 Jan-Mar;45(1):19-29. doi: 10.1080/08964289.2018.1432549. Epub 2018 Apr 4.
Mindfulness-based interventions (MBIs) have improved psychological outcomes for multiple chronic health conditions, including diabetes. A meta-analytic review of the literature was conducted on all located studies (n = 14) investigating MBIs that targeted diabetes-related distress (DRD) and diabetes-related outcomes among people with Type 1 and Type 2 diabetes. PsychInfo, PubMed, Medline, and Web of Science were searched for MBIs that were designed to improve DRD and other secondary outcomes, including quality of life and measures of metabolic control. A meta-analysis of these outcomes uncovered small-to-moderate effect sizes for intervention studies measuring pretreatment to posttreatment changes in DRD and metabolic control among treatment group participants. However, the pretreatment to follow-up comparisons for DRD and metabolic control were small and unreliable. For control groups, all pre-treatment to post-treatment and pre-treatment to follow-up comparisons were unreliable for all outcomes. A moderate effect size for treatment-control comparisons was found for intervention studies measuring quality of life outcomes at posttreatment, but not at follow-up comparisons. All other effect sizes for treatment-control comparisons were unreliable. Limitations and implications for MBIs among individuals with diabetes are discussed.
基于正念的干预措施（MBIs）已改善了多种慢性健康状况（包括糖尿病）的心理结局。对所有已找到的研究（n = 14）进行了文献荟萃分析，这些研究调查了针对1型和2型糖尿病患者的与糖尿病相关困扰（DRD）及糖尿病相关结局的MBIs。在PsychInfo、PubMed、Medline和科学网中搜索旨在改善DRD及其他次要结局（包括生活质量和代谢控制指标）的MBIs。对这些结局的荟萃分析发现，在测量治疗组参与者从治疗前到治疗后DRD和代谢控制变化的干预研究中，效应大小为小到中等。然而，DRD和代谢控制从治疗前到随访的比较结果较小且不可靠。对于对照组，所有从治疗前到治疗后以及从治疗前到随访的比较在所有结局方面均不可靠。在测量治疗后生活质量结局的干预研究中，发现治疗组与对照组比较的效应大小为中等，但在随访比较中并非如此。治疗组与对照组比较的所有其他效应大小均不可靠。文中讨论了糖尿病患者中MBIs的局限性及意义。
